Navidea Biopharmaceuticals Inc盘中异动股价大跌5.60%

自选股智能写手2023-10-03

北京时间2023年10月03日21时44分，Navidea Biopharmaceuticals Inc（NAVB.us）股票出现波动，股价快速下跌5.60%。截至发稿，该股报0.086美元/股，成交量32.7501万股，换手率0.33%，振幅2.53%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.39百万美元，每股收益0.12美元，毛利-36378.00美元，市盈率-0.36倍...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2372186728?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-10-03 21:44","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2372186728","market":"us","top_or_hot":-1,"title":"Navidea Biopharmaceuticals Inc盘中异动 股价大跌5.60%","media":"自选股智能写手","content":"<div>\n<p>北京时间2023年10月03日21时44分，Navidea Biopharmaceuticals Inc（NAVB.us）股票出现波动，股价快速下跌5.60%。截至发稿，该股报0.086美元/股，成交量32.7501万股，换手率0.33%，振幅2.53%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.39百万美元，每股收益0.12美元，毛利-36378.00美元，市盈率-0.36倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023100321440282f85b71&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Navidea Biopharmaceuticals Inc盘中异动 股价大跌5.60%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNavidea Biopharmaceuticals Inc盘中异动 股价大跌5.60%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-10-03 21:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023100321440282f85b71&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2023年10月03日21时44分，Navidea Biopharmaceuticals Inc（NAVB.us）股票出现波动，股价快速下跌5.60%。截至发稿，该股报0.086美元/股，成交量32.7501万股，换手率0.33%，振幅2.53%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.39百万美元，每股收益0.12美元，毛利-36378.00美元，市盈率-0.36倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023100321440282f85b71&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023100321440282f85b71&s=b","article_id":"2372186728","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023100321440282f85b71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2372186728","pubTimestamp":1696340641,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2023年10月03日21时44分，Navidea Biopharmaceuticals Inc股票出现波动，股价快速下跌5.60%。Navidea Biopharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Point Biopharma Global Inc、Seastar Medical Holding Corp C/Wts 28/10/2027 、Seastar Medical Holding Corp涨幅较大，Seastar Medical Holding Corp、Transcode Therapeutics Inc、Alx Oncology Hldgs Inc较为活跃，换手率分别为198.18%、59.79%、46.91%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Seastar Medical Holding Corp、Eqrx Inc C/Wts 17/12/2026 ，振幅分别为50.04%、36.43%、33.33%。Navidea Biopharmaceuticals Inc公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","NAVB":"Navidea生物制药"},"translate_title":"Shares of Naviidea Biopharmaceuticals Inc. tumbled 5.60% in intraday trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NAVB":1},"content_text":"北京时间2023年10月03日21时44分，Navidea Biopharmaceuticals Inc（NAVB.us）股票出现波动，股价快速下跌5.60%。截至发稿，该股报0.086美元/股，成交量32.7501万股，换手率0.33%，振幅2.53%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.39百万美元，每股收益0.12美元，毛利-36378.00美元，市盈率-0.36倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Navidea Biopharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Point Biopharma Global Inc、Seastar Medical Holding Corp C/Wts 28/10/2027 (To Pur Com)、Seastar Medical Holding Corp涨幅较大，Seastar Medical Holding Corp、Transcode Therapeutics Inc、Alx Oncology Hldgs Inc较为活跃，换手率分别为198.18%、59.79%、46.91%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 (To Pur Com)、Seastar Medical Holding Corp、Eqrx Inc C/Wts 17/12/2026 (To Pur Com)，振幅分别为50.04%、36.43%、33.33%。Navidea Biopharmaceuticals Inc公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。 其产品，精密免疫诊断剂和免疫治疗产品旨在帮助识别未发现的疾病并改善靶向治疗。 该公司的平台称为Manocept技术，旨在开发针对癌症，自身免疫性疾病和其他炎症性疾病的下一代靶向诊断和疗法。公司的产品之一是Lymphoseek，一种可定位淋巴结的放射性诊断剂。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2372186728"}

Navidea Biopharmaceuticals Inc盘中异动 股价大跌5.60%

精彩评论

Navidea Biopharmaceuticals Inc盘中异动股价大跌5.60%